FIGURE 3.
Intraperitoneal injection of A2ARPAM-2 induces sleep in mice with mania-like behavior. (A–O) Time course (A–F), total amount (G–I), mean duration (J–L), and episode number (M–O) of SWS, REMS, and wakefulness in VGAT-CreDTA/VMP and VGAT-CrehrGFP/VMP mice after administering saline or A2ARPAM-2. (P) Wake episode spectrum in VGAT-CreDTA/VMP mice. (Q) Latency to sleep onset in VGAT-CreDTA/VMP and VGAT-CrehrGFP/VMP mice after administering saline or A2ARPAM-2. (R,S) SWS EEG power density for 6 h after injection of saline or A2ARPAM-2 into VGAT-CreDTA/VMP (R) and VGAT-CrehrGFP/VMP (S) mice. Data (n = 6/group) are presented as mean ± SEM. Significance levels are indicated as *p < 0.05, **p < 0.01, and ***p < 0.001.